AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Plavas 150mg/75mg Tablet

Prescription Icon
Prescription Required

Marketer

Alembic Pharmaceuticals Ltd

Salt Composition

Aspirin (150mg) + Clopidogrel (75mg)

Overview Plavas 150mg/75mg Tablet

CardioGuard 150mg/75mg tablets combine two antithrombotic agents to inhibit blood clot development within blood vessels. Prescribed for heart disease patients to mitigate stroke or heart attack risk, it also treats acute coronary syndrome (ACS). Consistent daily intake with food, at evenly spaced intervals as directed, is crucial for effectiveness. Maintain the prescribed schedule; do not prematurely discontinue the treatment. Beneficial lifestyle adjustments – including a low-fat diet, regular exercise, and smoking cessation – can enhance its efficacy. Commonly reported side effects include dyspepsia, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption is generally discouraged. Prior to commencing treatment, inform your physician of any hepatic or renal conditions, pregnancy (planned or current), breastfeeding, or other medications you are currently using, as drug interactions may occur.

Uses of Plavas 150mg/75mg Tablet

Preventing heart attacks and strokes; managing acute coronary syndrome.

Major Benefits of Plavas 150mg/75mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Plavas 150mg/75mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Plavas 150mg/75mg Tablet:

  • Bruise
  • Gastrointestinal bleeding
  • Increased bleeding tendency
  • Nosebleeds

How to use Plavas 150mg/75mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Plavas 150mg/75mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Plavas 150mg/75mg Tablet works:

Combining aspirin and clopidogrel, Plavas 150mg/75mg tablets offer dual antiplatelet action to help prevent heart attacks. This medication inhibits platelet aggregation, thus reducing the risk of dangerous clot development. It's also indicated for the management of acute coronary syndrome.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Plavas 150mg/75mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Plavas 150mg/75mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administration of Plavas 150mg/75mg tablets while breastfeeding is likely inadvisable. Scant clinical evidence indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Plavas 150mg/75mg tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Plavas 150mg/75mg tablets, as dose modification may be necessary. Consult a physician for guidance. Plavas 150mg/75mg tablets are contraindicated in individuals with severely compromised kidney function.

LiverLiverCAUTION

Patients with liver impairment should use Plavas 150mg/75mg tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised. Plavas 150mg/75mg tablets are contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Plavas 150mg/75mg Tablet :

Should you forget a Plavas 150mg/75mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Plavas 150mg/75mg Tablet

LabelValue
Addictive None.
Medication Classification HEMATOLOGICAL

FAQs on Plavas 150mg/75mg Tablet

Patients receiving Plavas 150mg/75mg Tablets may have experienced a myocardial infarction, undergone percutaneous coronary intervention (PCI) with stent placement, or had coronary artery bypass grafting (CABG).
Plavas 150mg/75mg tablets function as an anticoagulant medication. The tablets inhibit platelet aggregation, thus preventing blood clot formation. This mechanism helps mitigate the risk of stroke or heart attack in patients with pre-existing heart conditions, those recovering from a myocardial infarction, or experiencing unstable angina.
Your physician will determine the necessary treatment length for Plavas 150mg/75mg Tablet. This timeframe depends on several factors, including your specific condition, the stent type implanted, and any bleeding episodes during treatment. A minimum one-year course is typical. Strict adherence to your doctor's instructions is crucial for optimal results. Never cease treatment independently; always consult your physician first. Abrupt cessation may significantly increase the risk of stent thrombosis, myocardial infarction, and even mortality.
Consuming alcohol alongside Plavas 150mg/75mg Tablet is discouraged due to the heightened risk of gastrointestinal hemorrhage. This risk manifests as potential hematemesis (vomiting blood, possibly bright red or dark brown resembling coffee grounds) or melena (bloody or dark, tarry stools). Consult your physician if you have any uncertainties.
Plavas 150mg/75mg Tablets can lead to severe, potentially fatal hemorrhaging. Increased bruising and prolonged bleeding, even from minor wounds, are possible. Seek immediate medical care for excessive or persistent bleeding. Report dark, tarry stools or blood in the urine to your physician. Watch for stroke symptoms including sudden numbness or weakness (unilateral or bilateral), gait difficulties, cognitive impairment, dysarthria, vertigo, and unexplained headaches. Since stroke, though infrequent, is a life-threatening complication of Plavas 150mg/75mg Tablets, promptly contact your doctor if any such symptoms appear.
Preoperative or pre-treatment cessation of Plavas 150mg/75mg Tablet will be determined by your physician. Elective procedures may necessitate discontinuation of Plavas 150mg/75mg Tablet several days (typically seven) prior to the intervention to mitigate the heightened risk of hemorrhage. Always consult your doctor before independently ceasing Plavas 150mg/75mg Tablet use.
Individuals with an allergy to Plavas 150mg/75mg Tablet or its components should not use this medication. The use of Plavas 150mg/75mg Tablet is contraindicated in patients with a history of, or current, severe hepatic impairment, peptic ulcers, cerebrovascular hemorrhage (stroke or transient ischemic attack), or hemophilia (a blood clotting disorder). Furthermore, Plavas 150mg/75mg Tablet should be avoided by women who are pregnant, breastfeeding, or attempting conception.
Remembered a missed dose of your Plavas 150mg/75mg Tablet? Take it immediately. But if your next dose is nearly due, omit the missed dose and continue with your regular schedule. Never take a double dose to compensate; doing so could heighten the risk of adverse reactions.
Minimize activities that could lead to bleeding. Exercise caution when shaving or brushing your teeth to avoid cuts. While ibuprofen and similar painkillers should generally be avoided, if necessary for conditions such as joint pain, headaches, or backaches, seek medical advice before taking them. Concomitant use of Plavas 150mg/75mg Tablet and pain relievers may heighten the risk of stomach ulcers and bleeding. Similarly, excessive alcohol consumption alongside Plavas 150mg/75mg Tablet should be avoided due to the increased risk of gastric irritation and ulceration.
Plavas 150mg/75mg Tablet
25
MRP 30
16% off